Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma

Recruiting

• Conditions: Kidney Cancer

• Registration Number: NCT03414827
• Lead Sponsor: Zealand University Hospital

Brief Summary

Recruitment of participants to the study takes place at the urological department at Zealand University Hospital, Roskilde, Feb. 2018-April 2018. 10 people with diagnosis of renal cancer should be recruited in phases 1. Subsequently, biological materials from 100 patients with kidney cancer will be used from the national Biobank. In phase 3, 10 patients will be recruited for the final gene test.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-01-13
• Study First Submitted QC: 2018-01-26
• Study First Posted: 2018-01-30
• Study Start: 2019-02-01
• Status Verified: 2024-01
• Last Update Submitted: 2024-01-27
• Last Update Posted: 2024-01-30
• Primary Completion: 2025-12-01
• Study Completion: 2027-12-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Patients who have been diagnosed with kidney cancer.

Exclusion Criteria

• Patients without signs of malignancy at final histology report.
• Incapacitated patients.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DNA	30 days	Sequence variation in specific genes

Trial Locations

Locations (1)

Zealand University Hospital; 🇩🇰 Roskilde, Denmark